Literature DB >> 21533776

Dahuang zhechong pill containing serum inhibited platelet-derived growth factor-stimulated vascular smooth muscle cells proliferation by inducing G1 arrest partly via suppressing protein kinase C α-extracellular regulated kinase 1/2 signaling pathway.

Na Liu1, Jun-tian Liu, Yuan-yuan Ji, Pei-pei Lu.   

Abstract

OBJECTIVE: To investigate effects of dahuang zhechong pill ( DHZCP) on the cell cycle and the related signal pathways in vascular smooth muscle cells (VSMCs) stimulated by platelet-derived growth factor (PDGF) with the method of serum pharmacology.
METHODS: DNA synthesis in VSMCs was examined by detecting 5'-bromo-2'-deoxyuridine incorporation with the immunocytochemical method. The cycle of VSMCs was evaluated with flow cytometry. Expressions of cyclin D1, p27, protein kinase Cα (PKCα), and phosphorylated extracellular signal regulated kinase 1/2 (ERK1/2) were quantified by Western blot method.
RESULTS: DHZCP containing serum significantly inhibited DNA synthesis of PDGF-stimulated VSMCs, arrested the cells in G G(1) phase, modulated the protein expressions of cyclin D D(1) and p27, and suppressed the activation of PKCα and ERK1/2.
CONCLUSION: DHZCP containing serum inhibits VSMCs proliferation via modulating the expressions of cell cycle proteins to arrest the cell in G G(1) phase, which is attributed to, at least in part, suppressing PKCα-ERK1/2 signaling in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533776     DOI: 10.1007/s11655-011-0696-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  26 in total

Review 1.  Flow cytometry in analysis of cell cycle and apoptosis.

Authors:  Z Darzynkiewicz; E Bedner; P Smolewski
Journal:  Semin Hematol       Date:  2001-04       Impact factor: 3.851

2.  PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells.

Authors:  Kenji Sakakibara; Kenji Kubota; Berhane Worku; Evan J Ryer; Jeffrey P Miller; Andrew Koff; K Craig Kent; Bo Liu
Journal:  J Biol Chem       Date:  2005-05-14       Impact factor: 5.157

3.  [Clinical application of Dahuang Zhechong Pill in gynecology].

Authors:  Hui-Xia Yuan
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-02

4.  Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase.

Authors:  P R Nelson; S Yamamura; L Mureebe; H Itoh; K C Kent
Journal:  J Vasc Surg       Date:  1998-01       Impact factor: 4.268

Review 5.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

6.  Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

Authors:  J N Lavoie; G L'Allemain; A Brunet; R Müller; J Pouysségur
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

7.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor.

Authors:  Yuji Saito; Yukihiro Hojo; Tatsuo Tanimoto; Jun-ichi Abe; Bradford C Berk
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

9.  Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C.

Authors:  R Marais; Y Light; C Mason; H Paterson; M F Olson; C J Marshall
Journal:  Science       Date:  1998-04-03       Impact factor: 47.728

10.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.